Bookmark list

TopoTarget establishes TopoTarget USA, Inc. and employs experienced marketeer as President

17-Nov-2006

TopoTarget A/S announced the establishment of TopoTarget USA, Inc. to be located in Rockaway, New Jersey near the center of the east coast U.S. pharmaceutical industry. TopoTarget USA, Inc. is scheduled to launch the company's first oncology product, Totect(TM), for the treat-ment of anthracycline induced extravasations in the first half of 2007.

TopoTarget selected John L. Parsons Jr., a veteran of the pharmaceutical industry, with 30 years of experience, to head the U.S. division. According to the company, his commercial experience spans most therapeutic areas, including oncology, and more than 20 successful product launches. Most recently, through his consulting company, Parsons Strategic Associates, John has been working closely with biotech companies in building commercial infrastructure to bring their products to market. In 2000, as Vice President of Emerging Markets at Quintiles, he worked with CV Therapeutics to launch Ranexa(TM). Most recently, he worked with Enzon Pharmaceuti-cals to build its commercial infrastructure to market specialty pharmaceutical products.

TopoTarget USA plans to launch its first product through its own sales force supplemented by outsourced resources for distribution. This announcement does not change TopoTarget's financial expectations for full-year 2006.

https://www.bionity.com/en/news/59533/topotarget-establishes-topotarget-usa-inc-and-employs-experienced-marketeer-as-president.html

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Acquisition strengthens Bayer’s drug discovery capabilities with cutting-edge chemoproteomics platform

Get the life science industry in your inbox

TopoTarget establishes TopoTarget USA, Inc. and employs experienced marketeer as President

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Other news from the department business & finance

Good overall result and revenue growth for the ZEISS Group

Merck to Acquire HUB Organoids Holding B.V.

Start-up EBViously founded

For better leukemia therapies: spin-off Cimeio partners with pharmaceutical company Kyowa Kirin

Lindis Blood Care announces successful financing for its tumour-cell-removal medical device

AQEMIA hits $100 million funding milestone

Concept Life Sciences and Accelero Biostructures partner to advance X-ray crystallography in early drug discovery

Orikine Bio secures €800k in innovation research funding to advance groundbreaking autoimmune disease therapy

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market

Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis

miDiagnostics secures €30 million Series D funding round led by Thermo Fisher Scientific

Capitainer participates in global AI project for advanced lung diagnostics

Eppendorf SE and DataHow AG announce strategic collaboration to advance bioprocess data management

IDEAward for researchers’ start-up ideas

Start-up aims to bring AI-powered protein engineering to every lab

Roche acquires Poseida Therapeutics

Körber acquires Bähren Pharma-Packaging

Bayer further expands global incubator network with Bayer Co.Lab Berlin and welcomes MyoPax as first resident

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site

Belgian start-up BIO INX and Carl ROTH partner to expand access to 3D bioprinting solutions

Get the life science industry in your inbox

Most read news

Microbe of the Year 2023: Bacillus subtilis – for health and technology

A new era of allergy treatment

CRISPR-Cas technology: ETH researchers have uncovered a serious side effect

‘Love hormone’ instead of opioids

Designing large new proteins with AI

Delivering medicines with microscopic flowers

Brain tumour cells rapidly integrate into brain-wide neuronal circuits

A stronghold in the fight against viruses - new bacterial immune system decoded

Concept Life Sciences and Accelero Biostructures partner to advance X-ray crystallography in early drug discovery

Cancer research: Small change with a big impact

From chip shop to pit stop

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market

More news from our other portals

Recycling batteries with citric acid

The science behind Magnum Bon Bon bite-sized ice creams

MIT gel changes color on demand

Plastic fantastic: Green, strong and edible

Food labeling in the EU is often misleading

Chemical analyses faster and more precise than ever before

Breakthrough in zinc-based rechargeable batteries: A safer, sustainable alternative

Beer like the Romans

Surfaces and Interfaces: Innovative techniques allow researchers to study interfaces with great precision

New method for new materials

Risk assessment: Essential ingredient for greater food safety

Smarter sensor sniffs out target gases

Researchers develop a new material that removes a dangerous “forever chemical,” from drinking water

Can AI improve plant-based meats?

Portable kit can recover traces of chemical evidence

Renewable Carbon Feedstocks: Building a Net-Zero Chemical Industry in 2050

Young people most stressed about spending family time this Christmas

Fresh iron from old mining sludge

Robots work in the bakery

Advanced Automation Technologies agrees to acquire GERSTEL

Why coffee needs an extra shot of Taylor Swift

Breakthrough: Previously unknown compound in chloraminated drinking water identified

Airy, delicious pastries with food foam made from peas

Liquid water molecules are inherently asymmetric

Color-Changing Test for Rapid Salmonella Detection

So close that even molecules turn red...

Last viewed contents

Prospect for more effective treatment of nerve pain - Trigeminal neuralgia: A glimmer of hope for patients – thanks to a newly tested substance

Nasonov

So close that even
molecules turn red...